cancer
debilit
diseas
afflict
substanti
portion
world
popul
gener
major
health
problem
global
concern
among
variou
type
cancer
colorect
cancer
second
third
preval
cancer
among
male
femal
unit
state
respect
spite
consider
progress
protect
method
recent
improv
screen
techniqu
chemotherapi
rel
surviv
rate
patient
suffer
colorect
cancer
respect
addit
due
bitter
controversi
optim
method
earli
detect
full
complianc
patient
screen
recommend
remain
major
hindranc
diagnosi
earli
stage
cancer
develop
develop
resist
chemotherapi
also
repres
critic
issu
simultan
treatment
variou
class
therapeut
reduc
resist
yield
success
moreov
numer
side
effect
chemotherapeut
drug
cancer
patient
includ
hair
loss
diarrhea
bleed
immunosuppress
made
process
treatment
complic
highli
regul
program
cell
death
process
apoptosi
matter
great
interest
oncolog
cancer
therapi
repres
common
molecular
pathway
drug
resist
carcinogenesi
mainten
constant
cell
number
colon
mucosa
highli
regul
balanc
apoptosi
cell
prolifer
perturb
balanc
lead
escap
normal
cell
number
homeostasi
associ
progress
cancer
cell
thu
suppress
prolifer
elev
apoptosi
aberr
cell
suggest
essenti
mechan
inhibit
colon
cancer
furthermor
apoptosi
factor
involv
mechan
action
also
present
window
exploit
improv
potenti
therapeut
agent
high
effect
less
advers
side
effect
henc
screen
novel
compound
capabl
induc
apoptosi
colon
cancer
cell
use
alon
combin
chemotherapeut
drug
signific
need
repres
critic
challeng
medicin
chemistri
metal
complex
extens
util
clinic
centuri
attract
numer
inorgan
chemist
analyz
main
focu
medic
applic
copper
essenti
trace
element
oxid
natur
bioessenti
activ
human
metabol
exist
ionic
form
biolog
system
thu
measur
copper
bodi
evalu
form
complex
organ
compound
schiff
base
critic
class
compound
medic
chemistri
demonstr
signific
chemotherapeut
antibacteri
applic
schiff
base
cu
ii
complex
reveal
great
potenti
antiprolif
antibacteri
gastroprotect
activ
studi
evalu
anticanc
potenti
copper
ii
complex
deriv
n
ethylen
diamin
schiff
base
ligand
cu
brhap
furthermor
possibl
apoptot
mechan
underli
activ
also
examin
chemic
obtain
sigmaaldrich
st
loui
mo
usa
unless
otherwis
indic
stock
solut
test
compound
prepar
dimethyl
sulfoxid
dmso
store
protect
light
previous
describ
copper
ii
complex
cu
brhap
figur
kindli
suppli
professor
dr
hapipah
mohd
ali
depart
chemistri
faculti
scienc
univers
malaya
kuala
lumpur
malaysia
human
colon
cancer
cell
ccd
normal
human
colon
epitheli
cell
purchas
american
type
cultur
collect
manassa
va
usa
maintain
routin
dulbecco
modifi
eagl
medium
dmem
life
technolog
inc
rockvil
md
contain
fetal
bovin
serum
streptomycin
uml
penicillin
g
humidifi
atmospher
air
cell
plate
fit
densiti
tissu
cultur
flask
corn
usa
accord
experiment
scale
cell
viabil
measur
convent
mtt
bromid
reduct
assay
h
exposur
six
concentr
cu
brhap
cell
treat
mtt
solut
mgml
h
dark
formazan
crystal
form
intact
cell
dissolv
dmso
absorb
measur
nm
nm
background
use
micropl
reader
hidex
turku
finland
valu
determin
concentr
cu
brhap
requir
reduc
absorb
treat
cell
dmsotreat
control
cell
sampl
prepar
triplic
measur
lactat
dehydrogenas
ldh
releas
biomark
determin
cytotox
compound
briefli
cell
treat
differ
concentr
cu
brhap
triton
posit
control
h
supernat
untreat
treat
cell
transfer
new
plate
ldh
activ
analysi
next
ldh
reaction
solut
ad
well
plate
incub
room
temperatur
min
absorb
read
nm
use
tecan
infinit
pro
tecan
switzerland
micropl
reader
amount
formazan
salt
intens
red
color
treat
untreat
sampl
repres
ldh
activ
cell
ldh
releas
level
cell
treat
cu
brhap
express
percentag
posit
control
propidium
iodid
pi
acridin
orang
ao
doubl
stain
assay
carri
detect
apoptosi
treat
cell
use
fluoresc
microscop
leica
attach
qfloro
softwar
accord
standard
procedur
cell
cellsml
ml
cultur
flask
plate
treat
cu
brhap
concentr
incub
h
harvest
cell
stain
fluoresc
dye
observ
uvfluoresc
microscop
olympu
within
min
brief
cell
cellswel
plate
supplement
cu
brhap
dmso
neg
control
h
live
cell
incub
brdu
phosphohiston
dye
min
cell
fix
stain
describ
manufactur
instruct
visual
analyz
use
cellom
arrayscan
hc
reader
thermo
scientif
fluoresc
intens
dye
measur
use
target
activ
bioapplic
modul
confirm
result
fluoresc
cell
cycl
analysi
cell
cellsml
treat
cu
brhap
h
flow
cytometri
analysi
incub
cell
spun
rpm
min
next
fixat
cell
popul
flow
cytometri
analysi
carri
restor
integr
brief
cell
pellet
fix
mix
cold
ethanol
kept
overnight
treat
cell
spun
ethanol
discard
wash
suspend
cell
pb
rnase
mgml
propidium
iodid
pi
mgml
ad
fix
cell
h
ad
rnase
limit
abil
pi
bind
dna
molecul
end
dna
content
cell
analyz
flow
cytomet
bd
facscanto
ii
oxygen
radic
antioxid
capac
orac
assay
carri
base
protocol
describ
detail
previous
brief
cu
brhap
concentr
use
assay
total
reaction
volum
experi
perform
black
micropl
compound
blank
solventpb
standard
trolox
posit
control
quercetin
plate
supplement
work
fluorescein
solut
follow
min
incub
total
volum
made
ad
aaph
work
solut
fluoresc
intens
measur
excit
wavelength
nm
emiss
wavelength
nm
everi
min
h
result
quantifi
calcul
differ
area
fluoresc
decay
curv
auc
sampl
blank
valu
trolox
equival
te
brief
cell
cellsml
seed
plate
treat
differ
concentr
cu
brhap
dmso
neg
control
h
min
treatment
dihydroethidium
dhe
dye
cell
fix
wash
wash
buffer
describ
manufactur
instruct
presenc
superoxid
dhe
dye
oxid
ethidium
fluoresc
intens
determin
fluoresc
plate
reader
extens
wavelength
nm
emiss
wavelength
nm
critic
factor
monitor
cell
health
name
cell
loss
chang
cell
permeabl
cytochrom
c
releas
mitochondri
membran
potenti
chang
nuclear
size
morpholog
chang
studi
use
cellom
multiparamet
cytotox
kit
describ
detail
previous
plate
stain
cell
analyz
use
arrayscan
hc
system
cellom
pa
usa
caspas
activ
determin
use
commerci
caspaseglo
assay
kit
promega
madison
wi
cell
cellswel
seed
overnight
whitewal
plate
treat
differ
concentr
cu
brhap
h
accord
manufactur
protocol
treat
cell
supplement
caspaseglo
reagent
incub
room
temperatur
min
activ
caspas
apoptot
cell
caus
cleavag
aminoluciferinlabel
synthet
tetrapeptid
lead
releas
substrat
luciferas
enzym
caspas
activ
analyz
use
tecan
infinit
pro
tecan
switzerland
micropl
reader
brief
cell
cellswel
plate
treat
differ
concentr
cu
brhap
h
follow
stimul
ngml
min
discard
medium
cell
fix
stain
use
cellom
nucleu
activ
kit
thermo
scientif
accord
manufactur
instruct
next
array
scan
hc
reader
use
evalu
plate
cytoplasm
nuclear
intens
ratio
calcul
use
cytoplasm
nucleu
transloc
bioapplic
softwar
averag
intens
cellswel
determin
ratio
untreat
treat
cell
compar
experi
perform
least
three
time
independ
result
present
mean
standard
deviat
sd
number
experi
shown
legend
analysi
varianc
anova
carri
use
prism
statist
packag
graphpad
softwar
usa
p
consid
statist
signific
initi
cytotox
cu
brhap
test
ccd
cell
line
valu
schiff
base
compound
determin
base
result
collect
three
independ
mtt
experi
indic
tabl
cu
brhap
elicit
signific
cytotox
cell
inhibitori
effect
h
treatment
cell
lactat
dehydrogenas
ldh
releas
medium
marker
show
loss
membran
integr
apoptosi
necrosi
cytotox
cu
brhap
compound
determin
ldh
releas
assay
quantifi
cell
treat
variou
concentr
schiff
base
compound
h
cu
brhap
induc
signific
elev
ldh
releas
demonstr
cytotox
concentr
compar
control
cell
figur
morpholog
chang
cell
treat
cu
brhap
compound
observ
fluoresc
microscop
h
cell
score
fluoresc
microscop
analyz
viabl
cell
earli
apoptosi
late
apoptosi
earli
apoptosi
defin
interven
ao
within
fragment
dna
observ
bright
green
fluoresc
time
control
cell
visual
green
intact
nuclear
structur
h
treatment
cu
brhap
moder
apoptosi
observ
form
bleb
nuclear
chromatin
condens
furthermor
late
stage
apoptosi
chang
presenc
reddishorang
color
due
bind
pi
denatur
dna
observ
h
treatment
figur
result
show
cu
brhap
compound
induc
morpholog
featur
apoptosi
timedepend
manner
cell
cycl
arrest
cell
treat
cu
brhap
carri
use
brdu
phosphohiston
dye
determin
whether
cell
arrest
sm
phase
comparison
treat
untreat
cell
shown
figur
demonstr
cell
cycl
arrest
sm
phase
lack
cell
cycl
arrest
sm
phase
suggest
possibl
cell
cycl
arrest
phase
determin
exact
arrest
phase
treat
cell
analyz
cell
cycl
progress
use
flow
cytometri
expect
signific
arrest
sm
phase
meanwhil
signific
cell
cycl
arrest
phase
observ
cell
h
treatment
figur
antioxid
capac
measur
orac
assay
assay
involv
use
peroxyl
radic
prooxid
quantifi
activ
via
area
curv
auc
techniqu
experi
quercetin
use
posit
control
result
demonstr
cu
brhap
exhibit
low
moder
antioxid
activ
compar
quercetin
tabl
cell
treat
differ
concentr
cu
brhap
h
stain
dhe
dye
determin
influenc
schiff
base
compound
ro
product
fluoresc
intens
dhe
oxid
ro
quantifi
use
fluoresc
micropl
reader
depict
figur
exposur
schiff
base
compound
caus
signific
elev
ro
level
treat
cell
concentr
investig
induct
apoptosi
cu
brhap
nuclear
morpholog
chang
cell
analyz
detect
nuclear
condens
shown
figur
hoechst
stain
demonstr
nuclear
condens
directli
relat
apoptot
chromatin
chang
emerg
cell
treatment
cu
brhap
meanwhil
permeabl
treat
cell
also
elev
mitochondria
main
sourc
product
ro
adenosin
triphosph
atp
critic
control
death
surviv
cell
reduct
fluoresc
intens
depict
figur
reflect
signific
decreas
mmp
cell
treat
schiff
base
compound
meanwhil
cu
brhap
trigger
transloc
cytochrom
c
mitochondria
cytosol
apoptosi
cell
elev
ro
product
associ
collaps
mmp
may
lead
activ
caspas
cascad
investig
caspas
activ
bioluminesc
intens
repres
caspas
activ
quantifi
cell
treat
differ
concentr
cu
brhap
h
shown
figur
signific
elev
activ
concentr
concentr
observ
cu
brhap
cell
signific
chang
activ
detect
treat
untreat
cell
thu
apoptosi
induc
schiff
base
compound
cell
possibl
mediat
via
intrins
pathway
extrins
pathway
nuclear
factor
kappa
b
transcript
factor
critic
role
cytokin
gene
express
activ
transloc
nucleu
enabl
dnabind
activ
facilit
target
gene
express
mediat
inflammatori
cytokin
tumor
necrosi
cu
brhap
schiff
base
compound
exhibit
inhibitori
effect
transloc
treat
cell
led
transloc
cytoplasm
nucleu
figur
carcinogenesi
multistag
process
unregul
cell
prolifer
well
reduct
apoptosi
incid
serv
initi
character
progress
one
defens
procedur
multicellular
organ
destruct
undesir
cell
develop
defin
program
cell
death
apoptosi
notic
program
cell
death
mechan
character
distinct
morpholog
chang
membran
permeabl
cell
shrinkag
disrupt
mitochondri
membran
chromatin
condens
disrupt
cellular
homeostasi
cell
death
cell
prolifer
lead
cancer
incid
agent
induc
apoptosi
known
potenti
anticanc
effect
apoptosi
pathway
effect
target
cancer
therapi
well
chemoprevent
numer
chemoprevent
drug
determin
regul
key
event
molecul
apoptosisinduc
signal
transduct
pathway
present
studi
cu
brhap
schiff
base
compound
evalu
abil
inhibit
growth
cell
use
mtt
assay
cell
recent
character
suitabl
model
colon
cancer
studi
cu
ii
complex
use
studi
exhibit
signific
inhibit
cell
growth
valu
rang
h
h
result
indic
schiff
base
complex
induc
antiprolif
effect
human
colon
cancer
cell
time
dosedepend
manner
meanwhil
nontumorigen
colon
cell
line
ccd
show
cytotox
treatment
compound
cytotox
effect
cu
ii
compound
also
confirm
measur
level
ldh
releas
treat
cell
consider
elev
ldh
releas
show
cytotox
cu
brhap
compound
possibl
occur
via
loss
membran
integr
whether
activ
apoptosi
necrosi
pathway
observ
earli
apoptosi
late
apoptosi
fluoresc
microscopi
analysi
aopi
doubl
stain
follow
treatment
cell
compound
includ
sign
apoptosi
name
cytoplasm
shrinkag
membran
bleb
dna
fragment
found
number
cell
earli
apoptosi
featur
higher
earlier
stage
treatment
howev
treatment
time
increas
h
late
apoptosi
necrosi
character
domin
among
treat
cell
concurr
detect
late
apoptosi
necrosi
scientif
possibl
treat
cell
undergo
apoptosi
may
progress
necrosi
due
prolong
incub
schiff
base
compound
elucid
mechan
underli
observ
antiprolif
effect
cu
ii
complex
cancer
cell
cell
cycl
distribut
analyz
use
brdu
phosphohiston
stain
along
flow
cytometri
brdu
dye
attach
synthes
dna
replic
cell
phase
cell
cycl
phosphohiston
dye
stain
cell
differ
mitot
stage
cell
cycl
result
brdu
phosphohiston
doubl
stain
assay
indic
signific
chang
number
cell
sm
phase
exposur
cell
schiff
base
compound
result
suggest
possibl
cell
arrest
phase
cell
cycl
thu
flow
cytometri
analysi
cell
cycl
perform
determin
exact
arrest
phase
result
demonstr
signific
cell
cycl
arrest
h
treatment
suggest
prolif
suppress
via
induct
apoptosi
perturb
mitochondri
membran
potenti
one
earliest
intracellular
event
occur
follow
induct
apoptosi
main
sourc
cellular
ro
adenosin
triphosph
atp
mitochondria
key
regul
mechan
control
surviv
death
cell
confirm
cu
brhap
schiff
base
compound
signific
antioxid
capac
cancer
cell
use
orac
assay
induct
ro
product
treat
cell
analyz
accord
studi
expos
cu
ii
compound
cell
analyz
level
ro
demonstr
level
ro
treat
cell
significantli
elev
compound
concentr
metalinduc
apoptosi
mitochondria
crucial
role
mediat
apoptosi
metalinduc
ro
intrins
mitochondrialdepend
signal
pathway
involv
differ
factor
nonreceptormedi
stimuli
induc
intracellular
signal
signal
mainli
protein
act
mitochondrialiniti
event
excess
ro
product
neg
signal
result
failur
suppress
antiapoptot
factor
therebi
trigger
apoptosi
therefor
use
mitochondri
membran
potenti
mmp
fluoresc
probe
examin
effect
elev
ro
product
function
mitochondria
treat
cell
shown
figur
chang
mmp
treatment
cu
brhap
schiff
base
compound
lead
membran
depolar
mitochondria
demonstr
rhodamin
releas
cytoplasm
mitochondria
matrix
result
impli
induct
apoptosi
cu
ii
schiff
base
complex
may
associ
mitochondri
pathway
one
import
signal
initi
procedur
apoptosi
cytosol
cytochrom
c
releas
cytochrom
c
cytosol
reduct
level
mitochondria
shown
occur
result
chang
mmp
result
illustr
synthet
schiff
base
compound
also
led
increas
level
cytochrom
c
cytosol
compar
control
excess
product
ro
mitochondria
collaps
mmp
may
activ
downstream
caspas
molecul
consequ
lead
apoptot
cell
death
bind
cytochrom
c
apoptot
activ
activ
via
apoptosom
format
lead
activ
effect
caspas
mani
cellular
target
extrins
pathway
apoptosi
mediat
death
receptor
exampl
fa
ligand
interact
fa
receptor
lead
activ
activ
cleav
activ
downstream
execution
caspas
studi
cu
brhap
schiff
base
compound
induc
signific
elev
caspas
activ
compar
control
meanwhil
activ
suggest
apoptosi
induc
cell
mediat
via
intrins
mitochondri
pathway
extrins
death
receptorlink
pathway
support
evid
ldh
releas
ro
product
mmp
suppress
elev
level
cytochrom
c
activ
caspas
demonstr
promis
anticanc
activ
cu
brhap
schiff
base
compound
colon
cancer
cell
line
via
intrins
mitochondri
pathway
